Journal of South China University of Technology(Natural Science) >

2026 , Vol. 54 >Issue 2: 102 - 111

DOI: https://doi.org/10.12141/j.issn.1000-565X.250302

Biological Engineering

Effect of Chicken Peptide-Ferrous Chelate on Iron Deficiency Anemia in Mice

  • LIU Ruili ,
  • SONG Xueying ,
  • MIAO Jinxin ,
  • ZHAO Mouming ,
  • SU Guowan
Expand
  • 1.School of Food Science and Engineering，South China University of Technology，Guangzhou 510640，Guangdong，China
    2.Academy of Chinese Medical Sciences，Henan University of Chinese Medicine，Zhengzhou 450046，Henan，China
刘蕊莉（1985—），女，博士，主要从事食品生物技术研究。E-mail： 306147380@qq.com

Received date: 2025-08-27

  Online published: 2025-09-15

Supported by

the Research and Development Program of China(2024YFF1106803)

Fold

Abstract

This study systematically investigated the ameliorative effect of Chicken Peptide-Ferrous Chelate (CMP-Fe) on anemia symptoms in mice with iron deficiency anemia (IDA). The intervention effects were comprehensively evaluated through multiple dimensions, including changes in body weight, blood routine parameters, iron metabolism indicators, inflammatory responses, and tissue protection. The experimental results showed that, compared to the model group, all CMP-Fe dose groups (with low-dose, medium-dose, and high-dose administered at Fe 1.0, 2.0 and 3.0 mg/kg, respectively, based on mouse body weight) exhibited significant improvements in body weight, blood routine parameters (including red blood cell count RBC, hemoglobin HGB, hematocrit HCT, mean corpuscular volume MCV, mean corpuscular hemoglobin MCH, mean corpuscular hemoglobin concentration MCHC, and red blood cell distribution width-coefficient of variation RDW-CV), and serum iron metabolism markers (including serum iron SI, total iron-binding TIBC, transferrin receptor TRF, ferritin FER, transferrin saturation TSAT, and unsaturated iron-binding capacity UIBC), with the high-dose group demonstrating the most pronounced effects. The ameliorative effects of CMP-Fe on erythrocyte-related parameters such as RBC, HGB, and HCT were comparable to those of the positive control group and exhibited a clear dose-dependent trend (low, medium, and high dose gradients). In terms of inflammation regulation, CMP-Fe could suppress the production of serum and colonic pro-inflammatory factors (IL-6, TNF-α, and CRP), while elevating the levels of the anti-inflammatory factor IL-10 and the intestinal mucosal immune marker sIgA. Specifically, the levels of pro-inflammatory factors such as IL-6, TNF-α, and CRP in the colonic tissues of mice in the CMP-Fe group were significantly lower than those in the model control group (P < 0.05), suggesting that CMP-Fe effectively modulates the inflammatory response asso-ciated with IDA. Notably, under high-dose CMP-Fe intervention, the recovery of sIgA levels in mice outperformed that of the model control group (P < 0.05) and even exceeded that of the positive control group. Histopathological examination shows that CMP-Fe causes no significant pathological damage to organs such as the heart, lungs, spleen, and kidneys in mice, indicating its favorable biosafety. Meanwhile, this chelate also significantly alleviates pathological injuries in intestinal and liver tissues caused by iron deficiency. In conclusion, CMP-Fe effectively alleviates iron metabolism disorders, inhibits inflammatory responses, and mitigates intestinal and liver tissue damage in mice with IDA, while demonstrating good safety. As a promising novel organic iron supplement, it holds potential for application in the development of specialized pet foods and nutritional supplements for various animals such as cats and dogs.

Key words： Chicken Peptide-Ferrous Chelate; iron deficiency anemia; iron metabolism; inflammation regulation

Cite this article

LIU Ruili , SONG Xueying , MIAO Jinxin , ZHAO Mouming , SU Guowan . Effect of Chicken Peptide-Ferrous Chelate on Iron Deficiency Anemia in Mice[J]. Journal of South China University of Technology(Natural Science), 2026 , 54(2) : 102 -111 . DOI: 10.12141/j.issn.1000-565X.250302

References

[1] ERRI??E-JERVILD M， KRUU?E C， WEGLEWSKI A，et al ．Iron deficiency anemia as a risk factor associated with stroke and cerebral venous thrombosis in children and adults：a systematic review［J］．Thrombosis Research，2025，253：109425/1-8.
[2] WICHERT B， SCHADE L， GEBERT S，et al ．Energy and protein needs of cats for maintenance，gestation and lactation［J］．Journal of Feline Medicine and Surgery，2009，11（10）：808-815.
[3] SILVA I C DA， DOS SANTOS P D S， DOS SANTOS JúNIOR O O，et al ．Influence of mineral source and inclusion levels of iron，copper，and zinc on the oxidative stability of extruded cat food［J］．Animal Feed Science and Technology，2024，315：115997/1-13.
[4] ROUT S R， PRADHAN D， HALDAR J，et al ．Recent advances in the formulation strategy to improve iron bioavailability：a review［J］．Journal of Drug Delivery Science and Technology，2024，95：105633/1-14.
[5] 丁刘刚，关婷，缪金典，等 ．软骨及姜黄联合葛根薏仁提取物对膝骨关节炎大鼠软骨损伤的改善作用［J］．华南理工大学学报（自然科学版），2024，52（4）：17-25.
  DING Liugang， GUAN Ting， MIAO Jindian，et al ．Improvement effects of co-administration of cartilage extract，turmeric extract，pueraria lobata and coix seed extract on cartilage damage of rats with knee osteoarthritis［J］．Journal of South China University of Technology（Natural Science Edition），2024，52（4）：17-25.
[6] LIN S， HU X， YANG X，et al ．GLPGPSGEEGKR：Fe2+ chelating characterization and potential transport pathways for improving Fe2+ bioavailability in Caco-2 cells［J］．Food Bioscience，2022，48：101806/1-12.
[7] DING X， XU M， LI H，et al ．Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate［J］．Food Research International，2024，190：114602/1-9.
[8] 周雪松，赵谋明，林伟锋，等 ．Alcalase酶解鸡肉蛋白及产物的自由基清除活性［J］．华南理工大学学报（自然科学版），2006，34（3）：117-122.
  ZHOU Xue-song， ZHAO Mou-ming， LIN Wei-feng，et al ．Enzymatic hydrolysis of chicken protein by alcalase and scavenging activity of resulted hydrolysates on free radicals［J］．Journal of South China University of Technology　（Natural Science Edition），2006，34（3）：117-122.
[9] 吴佳瑄，廖瑞生，况文明，等 ．国产鸡肉粉替代鱼粉对大口黑鲈生长性能、肝脏健康及肠道屏障的影响［J］．水产学报，2023，47（10）：109605/1-11.
  WU Jiaxuan， LIAO Ruisheng， KUANG Wenming，et al ．Effects of replacing fish meal with domestic poultry by-product meal on growth，liver health and intestinal barrier of Micropterus salmoides ［J］．Journal of Fisheries of China，2023，47（10）：109605/1-11.
[10] CHEN J， YAN Y， ZHANG L，et al ．Purification of novel antioxidant peptides from myofibrillar protein hydrolysate of chicken breast and their antioxidant potential in chemical and H2O2-stressed cell systems［J］．Food & Function，2021，12（11）：4897-4908.
[11] 闫昌誉，丁肇俊，李晓敏，等 ．鸡源性活性肽的研究进展［J］．今日药学，2022，32（1）：4-16.
  YAN Changyu， DING Zhaojun， LI Xiaomin，et al ．Research progress of chicken-derived active peptides［J］．Pharmacy Today，2022，32（1）：4-16.
[12] 王彦芝 ．菜籽肽亚铁螯合物的制备及特性研究［D］．郑州：河南工业大学，2025.
[13] 管玲娟 ．阿胶肽铁螯合物调控缺铁性贫血小鼠肠道炎症的作用及其微胶囊化研究［D］．无锡：江南大学，2022.
[14] 梅迪鹏 ．大豆鲜味肽的制备及呈味机理研究［D］．广州：华南理工大学，2024.
[15] SUN N， WANG Z， JIANG H，et al ．Angelica sinensis polysaccharides promote extramedullary stress erythropoiesis via ameliorating splenic glycolysis and EPO/STAT5 signaling-regulated macrophages［J］．Journal of Molecular Histology，2024，55（5）：661-673.
[16] ?ETINKAYA ALTUNTA? S， EVRAN M， GüRKAN E，et al ．HbA1c level decreases in iron deficiency anemia［J］．Wiener Klinische Wochenschrift，2021，133：102-106.
[17] CANNY S P， OROZCO S L， THULIN N K，et al ．Immune mechanisms in inflammatory anemia［J］．Annual Review of Immunology，2023，41（1）：405-429.
[18] TORSVIK I K， MARKESTAD T， UELAND P M，et al ．Evaluating iron status and the risk of anemia in young infants using erythrocyte parameters［J］．Pediatric Research，2013，73（2）：214-220.
[19] ZHANG H， SUN W， QI J，et al ．Antianemic activity，inhibition of oxidative stress，and iron supplementation in mice with iron-deficiency anemia through HG-hawthorn pectin-iron （Ⅲ） complexes［J］．ACS Applied Bio Materials，2025，8（3）：2419-2428.
[20] YASSIN M A， ALMASRI H A， AL-TIKRITY M A，et al ．Neutropenia and lymphocytopenia among arab females with iron deficiency anemia （IDA） and their response to iron therapy［J］．Acta Bio-Medica：Atenei Parmensis，2022，93（3）：e2022235/1-7.
[21] SABOOR M， ZEHRA A， HAMALI H A，et al ．Revisiting iron metabolism，iron homeostasis and iron deficiency anemia［J］．Clinical Laboratory，2021，67（3）：660-666.
[22] GOSAVI R， JADHAV N B， NASHTE A ．Intravenous iron technique evaluation in chronic heart failure with iron deficiency anemia［J］．Cureus，2023，15（10）：e47778/1-8.
[23] PAGANI A， NAI A， SILVESTRI L，et al ．Hepcidin and anemia：a tight relationship［J］．Frontiers in Physiology，2019，10：1294/1-7.
[24] GRIGOROPOULOS I， TSIOULOS G， KASTRISSIA-NAKIS A，et al ．The safety and potential efficacy of exosomes overexpressing CD24 （EXO-CD24） in mild-moderate COVID-19 related ARDS［J］．Respiratory Research，2024，25（1）：151/1-13.
[25] HIRANO T ．IL-6 in inflammation，autoimmunity and cancer［J］．International Immunology，2021，33（3）：127-148.
[26] BORGONETTI V， COCETTA V， BIAGI M，et al ．Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium［J］．Minerva Pediatric，2022，74（5）：511-518.
[27] WEISS G， GANZ T， GOODNOUGH L T ．Anemia of Inflammation［J］．Blood，2019，133（1）：40-50.
[28] TANOUS O， LEVIN C， SUCHDEV P S，et al ．Resolution of iron deficiency following successful eradication of Helicobacter pylori in children［J］．Acta Paedia-trica，2022，111（5）：1075-1082.
Options
Outlines

/

〈 〉